FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

Go back to FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
(NASDAQ: FBLG) Delayed: 0.81 +0.04 (5.19%)
Previous Close $0.77    52 Week High
Open $0.76    52 Week Low
Day High $0.82    P/E N/A 
Day Low $0.75    EPS
Volume 158,133